INFUSYSTEM HOLDINGS, INC Revenue, Net (Deprecated 2018-01-31)
INFUSYSTEM HOLDINGS, INC (INFU) reported Revenue, Net (Deprecated 2018-01-31) of $71.08 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-19.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-03-19
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $18.89M, a 12.10% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $17.59M, a 2.10% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $16.94M, a 6.52% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $17.65M, a 3.50% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for fiscal 2017 was $71.08M, a 0.82% increase from fiscal 2016.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for fiscal 2016 was $70.50M, a 0.06% decline from fiscal 2015.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for fiscal 2015 was $70.54M, a 6.10% increase from fiscal 2014.
- INFUSYSTEM HOLDINGS, INC revenue, net (deprecated 2018-01-31) for fiscal 2014 was $66.49M, a 6.75% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $18.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $36.48M derived: sum of 2 quarters · filed 2018-03-19 | $53.42M derived: sum of 3 quarters · filed 2018-03-19 | $71.08M 10-K · filed 2018-03-19 | ||||
| 2017-09-30 | $17.59M 10-Q · filed 2017-11-13 | $34.53M derived: sum of 2 quarters · filed 2017-11-13 | $52.18M 10-Q · filed 2017-11-13 | $69.04M derived: sum of 4 quarters · filed 2018-03-19 | ||||
| 2017-06-30 | $16.94M 10-Q · filed 2017-08-09 | $34.60M 10-Q · filed 2017-08-09 | $51.45M derived: sum of 3 quarters · filed 2018-03-19 | $68.68M derived: sum of 4 quarters · filed 2018-03-19 | ||||
| 2017-03-31 | $17.65M 10-Q · filed 2017-05-15 | $34.51M derived: sum of 2 quarters · filed 2018-03-19 | $51.73M derived: sum of 3 quarters · filed 2018-03-19 | $69.86M derived: sum of 4 quarters · filed 2018-03-19 | ||||
| 2016-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $34.08M derived: sum of 2 quarters · filed 2018-03-19 | $52.20M derived: sum of 3 quarters · filed 2018-03-19 | $70.50M 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $17.23M 10-Q · filed 2017-11-13 | $35.35M derived: sum of 2 quarters · filed 2017-11-13 | $53.64M 10-Q · filed 2017-11-13 | $72.39M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $18.12M 10-Q · filed 2017-08-09 | $19.07M 10-Q · filed 2016-08-10 | $36.42M 10-Q · filed 2017-08-09 | $38.11M 10-Q · filed 2016-08-10 | $55.16M derived: sum of 3 quarters · filed 2017-08-09 | $73.47M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | $18.29M 10-Q · filed 2017-05-15 | $19.04M 10-Q · filed 2016-05-10 | $37.04M derived: sum of 2 quarters · filed 2017-05-15 | $55.35M derived: sum of 3 quarters · filed 2017-05-15 | $72.28M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $18.74M 10-K/A · filed 2016-12-12 | $37.05M derived: sum of 2 quarters · filed 2016-12-12 | $53.99M derived: sum of 3 quarters · filed 2016-12-12 | $70.54M 10-K · filed 2017-03-22 | $72.13M 10-K · filed 2016-03-09 | |||
| 2015-09-30 | $18.31M 10-K/A · filed 2016-12-12 | $18.69M 10-Q · filed 2015-11-12 | $35.25M derived: sum of 2 quarters · filed 2016-12-12 | $51.80M 10-K/A · filed 2016-12-12 | $52.59M 10-Q · filed 2015-11-12 | $68.06M derived: sum of 4 quarters · filed 2016-12-12 | ||
| 2015-06-30 | $16.94M 10-K/A · filed 2016-12-12 | $33.49M 10-K/A · filed 2016-12-12 | $33.90M 10-Q · filed 2015-08-13 | $49.75M derived: sum of 3 quarters · filed 2016-12-12 | $66.36M derived: sum of 4 quarters · filed 2016-12-12 | |||
| 2015-03-31 | $16.55M 10-K/A · filed 2016-12-12 | $16.73M 10-Q · filed 2015-05-12 | $32.81M derived: sum of 2 quarters · filed 2016-12-12 | $49.42M derived: sum of 3 quarters · filed 2016-12-12 | $65.80M derived: sum of 4 quarters · filed 2016-12-12 | |||
| 2014-12-31 | $16.26M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | $32.87M derived: sum of 2 quarters · filed 2016-12-12 | $49.24M derived: sum of 3 quarters · filed 2016-12-12 | $66.49M 10-K/A · filed 2016-12-12 | ||||
| 2014-09-30 | $16.61M 10-Q · filed 2015-11-12 | $32.98M derived: sum of 2 quarters · filed 2015-11-12 | $50.23M 10-Q · filed 2015-11-12 | $67.40M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | $16.37M 10-Q · filed 2015-08-13 | $33.61M 10-Q · filed 2015-08-13 | $50.79M derived: sum of 3 quarters · filed 2015-08-13 | $66.53M derived: sum of 4 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | $17.24M 10-Q · filed 2015-05-12 | $34.42M derived: sum of 2 quarters · filed 2015-05-12 | $50.16M derived: sum of 3 quarters · filed 2015-05-12 | $64.82M derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2013-12-31 | $17.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $32.92M derived: sum of 2 quarters · filed 2015-03-09 | $47.58M derived: sum of 3 quarters · filed 2015-03-09 | $62.28M 10-K · filed 2015-03-09 | ||||
| 2013-09-30 | $15.74M 10-Q · filed 2014-11-10 | $30.40M derived: sum of 2 quarters · filed 2014-11-10 | $45.10M 10-Q · filed 2014-11-10 | $61.34M derived: sum of 4 quarters · filed 2014-11-10 | ||||
| 2013-06-30 | $14.66M 10-Q · filed 2014-08-01 | $29.36M 10-Q · filed 2014-08-01 | $45.60M derived: sum of 3 quarters · filed 2014-08-01 | $59.77M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2013-03-31 | $14.70M 10-Q · filed 2014-05-05 | $30.93M derived: sum of 2 quarters · filed 2014-05-05 | $45.11M derived: sum of 3 quarters · filed 2014-05-05 | $59.18M derived: sum of 4 quarters · filed 2014-05-05 | ||||
| 2012-12-31 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $30.41M derived: sum of 2 quarters · filed 2014-03-11 | $44.48M derived: sum of 3 quarters · filed 2014-03-11 | $58.83M 10-K · filed 2014-03-11 | ||||
| 2012-09-30 | $14.18M 10-Q · filed 2013-11-12 | $28.25M derived: sum of 2 quarters · filed 2013-11-12 | $42.59M 10-Q · filed 2013-11-12 | $56.64M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $14.07M 10-Q · filed 2013-08-13 | $28.42M 10-Q · filed 2013-08-13 | $42.46M derived: sum of 3 quarters · filed 2013-08-13 | $56.97M derived: sum of 4 quarters · filed 2013-08-13 | ||||
| 2012-03-31 | $14.35M 10-Q · filed 2013-05-13 | $28.39M derived: sum of 2 quarters · filed 2013-05-13 | $42.90M derived: sum of 3 quarters · filed 2013-05-13 | $56.03M derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | $14.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $28.55M derived: sum of 2 quarters · filed 2013-03-28 | $41.68M derived: sum of 3 quarters · filed 2013-03-28 | $54.64M 10-K · filed 2013-03-28 | ||||
| 2011-09-30 | $14.51M 10-Q · filed 2012-11-14 | $27.64M derived: sum of 2 quarters · filed 2012-11-14 | $40.59M 10-Q · filed 2012-11-14 | $53.67M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $13.13M 10-Q · filed 2012-08-08 | $26.09M 10-Q · filed 2012-08-08 | $39.16M derived: sum of 3 quarters · filed 2012-08-08 | $51.90M derived: sum of 4 quarters · filed 2012-08-08 | ||||
| 2011-03-31 | $12.96M 10-Q · filed 2012-05-21 | $26.03M derived: sum of 2 quarters · filed 2012-05-21 | $38.77M derived: sum of 3 quarters · filed 2012-05-21 | $49.25M derived: sum of 4 quarters · filed 2012-05-21 | ||||
| 2010-12-31 | $13.07M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $25.81M derived: sum of 2 quarters · filed 2012-03-16 | $36.30M derived: sum of 3 quarters · filed 2012-03-16 | $47.23M 10-K · filed 2012-03-16 | ||||
| 2010-09-30 | $12.73M 10-Q · filed 2011-11-14 | $23.22M derived: sum of 2 quarters · filed 2011-11-14 | $34.15M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $10.49M 10-Q · filed 2011-08-15 | $21.42M 10-Q · filed 2011-08-15 | ||||||
| 2009-12-31 | $38.96M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |